Byline: Kiplinger Washington Editors Shares of biotechnology company Genentech (DNA) have had a big couple of months. In March, shares soared 25% in one day on news that the firm's cancer drug Avastin performed well in a clinical trial. The stock rocketed another 18% on April 15 after more positive ... (Publication: Kiplinger's Pick of the Day Web Feature)
↧